drugset / Trial / NCT01591330
A Study of LY2140023 in Healthy Males and Females
RandomizedCrossoverOpen-labelTreatment
Summary
The study will evaluate the effect of different particle size of LY2140023. The study involves 4 single doses of 80 milligrams (mg) LY2140023 taken as 1 tablet by mouth with a washout period of at least 3 days between doses. This study will last approximately 60 days not including screening. Screening is required within 30 days prior to study entry.
Timeline
- Start
- 2012-04
- Primary completion
- 2012-06
- Completion
- 2012-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LY2140023 | Unknown | 80 mg | Oral |
Indications
No indication recorded.